Wordt geladen...
Indoleamine 2,3-dioxygenase vaccination
Indoleamine 2,3-dioxygenase (IDO) is an immunoregulatory enzyme. Remarkably, we discovered IDO-specific T cells that can influence adaptive immune reactions in patients with cancer. Further, a recent phase I clinical trial demonstrated long-lasting disease stabilization without toxicity in patients...
Bewaard in:
| Gepubliceerd in: | Oncoimmunology |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4368142/ https://ncbi.nlm.nih.gov/pubmed/25949864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/2162402X.2014.983770 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|